Therapeutic Hypothermia Systems Market, By Product Type (Cooling Devices, Cooling Catheters, Cooling Packs), Indication (Neurology, Cardiology, Neonatal Care), End-use (Hospitals, Specialty Clinics, ASCs) – Global Forecast, 2024 – 2032

Therapeutic Hypothermia Systems Market Size

Therapeutic Hypothermia Systems Market size was valued at around USD 286.2 million in 2023 and is estimated to reach USD 433.2 million by 2032 with a CAGR of 4.8% over the forecast period. This robust market growth can be attributed to factors such as the increasing prevalence of cardiovascular and neurological disorders coupled with the growing awareness of the benefits of therapeutic hypothermia.
 

The rising prevalence of cardiovascular and neurological disorders has led to an expansion in the indications for therapeutic hypothermia. Clinical studies and medical guidelines increasingly recommend hypothermic therapy for conditions such as cardiac arrest, stroke, and traumatic brain injury, driving the demand for therapeutic hypothermia systems. For instance, according to the Sudden Cardiac Arrest Foundation, in 2022, there were more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the U.S.
 

Therapeutic hypothermia systems refer to medical devices designed to induce and maintain a controlled reduction in body temperature for therapeutic purposes. This deliberate cooling of the body, typically within a precise temperature range, is employed as a therapeutic intervention in various medical conditions, particularly those involving neurological and cardiovascular disorders.
 

Therapeutic Hypothermia Systems Market Trends

Ongoing technological advancements have led to the development of therapeutic hypothermia systems with enhanced precision in temperature control. Modern systems incorporate sophisticated sensors and algorithms, allowing healthcare providers to maintain precise and stable target temperatures, optimizing the therapeutic benefits of controlled cooling.
 

• The integration of closed-loop feedback systems is a key technological advancement in therapeutic hypothermia. These systems continuously monitor the patient's temperature and adjust cooling interventions in real time, ensuring optimal therapeutic conditions. The closed-loop feedback mechanism enhances the efficiency and safety of therapeutic hypothermia procedures.
   
• Moreover, technological innovations have introduced non-invasive cooling techniques in therapeutic hypothermia systems. Non-invasive methods, such as surface cooling fabrics or pads, offer effective cooling without the need for invasive procedures. This advancement improves patient comfort, reduces complications, and expands the applicability of therapeutic hypothermia in various clinical settings.
   
• Furthermore, modern therapeutic hypothermia systems integrate advanced monitoring capabilities, providing real-time data on vital signs, neurological status, and cooling parameters. The integration of comprehensive monitoring enhances the ability of healthcare providers to closely observe patient responses, ensuring safety and optimizing the therapeutic outcomes of hypothermic therapy, leading to improved surgical outcomes, and augmenting the market growth positively.
   

Therapeutic Hypothermia Systems Market Analysis

Based on product type, the market is categorized into cooling devices, cooling catheters, cooling packs, and other product types. The cooling devices segment was valued at over USD 141.2 million in revenue in 2023.
 

• The evolution of therapeutic hypothermia systems is driven by the development of diverse cooling modalities. Cooling devices now offer a range of options, including surface cooling methods such as cooling blankets, caps, and pads, as well as invasive techniques like intravascular cooling catheters. The availability of multiple modalities allows healthcare providers to tailor cooling interventions based on patient needs and conditions.
   
• Additionally, cooling devices equipped with closed-loop temperature control mechanisms enhance their effectiveness. Closed-loop systems continuously monitor patient temperature and adjust cooling interventions in real time, ensuring tight control within the desired therapeutic range. This level of precision contributes to improved patient outcomes and safety, solidifying their dominant market share.
   

Based on indication, the therapeutic hypothermia systems market is segmented into neurology, cardiology, neonatal care, and other indications. The neurology segment held the leading revenue share in 2023 and is anticipated to reach USD 166.1 million by 2032.
 

• The increasing prevalence of ischemic stroke cases has elevated the demand for therapeutic hypothermia systems. According to the Centers for Disease Control and Prevention, in 2021, about 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. Therapeutic hypothermia has shown promise in mitigating ischemic brain injury, and as a result, healthcare providers are incorporating these systems into stroke management protocols to improve patient outcomes.
   
• Further, the growth of neurological intensive care units (NICUs) has created a conducive environment for the adoption of therapeutic hypothermia systems. These systems are increasingly utilized in NICUs to manage various neurological conditions, including neonatal hypoxic-ischemic encephalopathy (HIE), demonstrating their versatility in addressing neurological challenges across diverse patient populations, thereby driving the adoption of these treatments.

Based on end-use, the therapeutic hypothermia systems market is segmented into hospitals, speciality clinics, and ambulatory surgical centers. The hospitals segment accounted for USD 159.5 million in revenue in 2023.
 

• The prevalence of intensive care units within hospitals creates a conducive environment for the adoption of therapeutic hypothermia systems. These systems find extensive use in ICUs to address critical neurological and cardiovascular conditions, emphasizing hospitals' role as primary users and contributors to the market's expansion.
   
• Moreover, hospitals with specialized neurological and cardiac care departments are instrumental in the growth of therapeutic hypothermia systems. The unique requirements of treating neurological and cardiac emergencies make these hospitals key stakeholders, driving the demand for systems designed to address specific conditions in these specialized units.

North America therapeutic hypothermia systems market accounted for USD 115.9 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The prevalence of cardiovascular and neurological disorders in North America serves as a significant growth driver for the market. The region experiences a high incidence of conditions such as cardiac arrest, stroke, and traumatic brain injury, creating a substantial demand for therapeutic hypothermia interventions.
   
• Moreover, ongoing investments in medical research and innovation within North America drive advancements in therapeutic hypothermia systems. Collaborations between research institutions, healthcare organizations, and industry players lead to the development of more effective and efficient cooling devices, positioning North America as a hub for technological innovation in the market.
   

Therapeutic Hypothermia Systems Market Share

The therapeutic hypothermia systems industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel treatments with improved efficiency and cost-effectiveness are among a key market strategy for therapeutic hypothermia system manufacturers.
 

Therapeutic Hypothermia Systems Market Companies

Some of the eminent market participants operating in the therapeutic hypothermia systems industry include:

• Asahi Kasei Corporation
• Audax Management Company, LLC.
• Becton, Dickinson and Company
• EM-MED Sp. z o.o. Sp. K.
• Gentherm Incorporated
• International Biomedical Ltd.
• Phoenix Medical Systems Pvt. Ltd.
• Shenzhen Comen Medical Instruments Co., Ltd.
• Stryker Corporation
• Terumo Corporation
   

Therapeutic Hypothermia Systems Industry News:

• In January 2024, SourceMark announced an expanded partnership with Gentherm Medical, a leading manufacturer of patient temperature management systems. SourceMark is now the master supplier of certain Gentherm product lines in the United States, including Gelli-Roll, a reusable warming and cooling gel pad. This partnership may help Gentherm to expand its presence in the market.
   
• In July 2023, ZOLL, an Asahi Kasei company announced that it has entered into an agreement with BrainCool, for the exclusive distribution of the BrainCool System/IQool System and the IQool System Pads in the U.S. and key markets in Europe and is working towards expanding distribution to select markets in Asia. This partnership may help the company to gain a competitive edge over its peers and acquire an enhanced customer base.
   

The therapeutic hypothermia systems market research report includes an in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Cooling devices
• Cooling catheters
• Cooling packs
• Other product types

Market, By Indication

• Neurology
• Cardiology
• Neonatal care 
• Other indications

Market, By End-use

• Hospitals
• Specialty clinics
• Ambulatory surgical centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa